focus -WSS

focus

author：entertainment 2025-08-26 23:44:22 - browse：5941

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

WSS

What will save rural psychiatry services? Higher Medicaid payments

Report: NIH

Study finds gene variants tied to breast cancer risk in Black women

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Report: NIH

Average age of first period drops to 11.9 years, study shows

hotspot

focus

entertainment

The high cost of giving birth even with insurance

Liver decline slowed by off

Virginia high school admissions case could be legal follow

Scientists successfully use ultrasound imaging to map brain activity

How to save PrEP access — and even expand it

Fentanyl is making it harder to start addiction treatment

Moonlake's readout produced a cash windfall. Risks remain

Focused ultrasound for uterine fibroids: an uphill battle

23andMe had bad news about my health. I wish a person had delivered it

Study finds gene variants tied to breast cancer risk in Black women

focus

FDA poised to publish guidelines for clinical trial diversity

ASCO eve: Let’s set the table for this year's meeting

Listen: More tumult at BIO & coercive care for sickle cell patients

Eyeing GLP

H5N1 bird flu outbreak: Second human case reported, in Michigan

Listen: More tumult at BIO & coercive care for sickle cell patients

explore

entertainment

explore

Wikipedia